A detailed history of State Of New Jersey Common Pension Fund D transactions in Vaxcyte, Inc. stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 39,474 shares of PCVX stock, worth $3.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
39,474
Previous 39,474 -0.0%
Holding current value
$3.5 Million
Previous $2.98 Million 51.21%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$60.06 - $78.77 $838,137 - $1.1 Million
-13,955 Reduced 26.12%
39,474 $2.98 Million
Q1 2024

May 02, 2024

BUY
$59.79 - $81.05 $301,819 - $409,140
5,048 Added 10.43%
53,429 $3.65 Million
Q2 2023

Aug 02, 2023

SELL
$34.66 - $54.07 $150,493 - $234,771
-4,342 Reduced 8.24%
48,381 $2.42 Million
Q4 2022

Feb 01, 2023

BUY
$20.58 - $47.95 $1.09 Million - $2.53 Million
52,723 New
52,723 $2.53 Million

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.25B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.